Product Information
GRANISETRON HCL 1 MG TABLET is a generic product labeled by Breckenridge Pharmaceutical Inc., priced at $1.3050 per EA under NDC 51991073532. Its NADAC has been published 518 times since Nov 28, 2013.
FDA first approved this application on Jun 22, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1 mg/1
Manufacturer
Breckenridge Pharmaceutical Inc.NDC
51991073532
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
GRANISETRON HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078969FDA Approved
6/22/2009
TE Code
AB
On Market Since
6/22/2009
Pharmacological Classes
Price Statistics
The NADAC for GRANISETRON HCL 1 MG TABLET has been published 518 times since Nov 28, 2013, and over the history we have for it it has declined 70.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.3050 per EA |
|---|---|
| All-time high | $4.4661 (Feb 12, 2014) |
| All-time low | $1.0638 (Jun 19, 2024) |
| 52-week high | $1.6179 |
| 52-week low | $1.0722 |
| Median price | $1.8861 |
| Average price | $2.1355 |
| Largest weekly change | +83.8% (Jul 19, 2017) |
| Weeks tracked | 518 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Breckenridge Pharmaceutical Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Granisetron Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin-3 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GRANISETRON HCL 1 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GRANISETRON HCL 1 MG TABLET, manufactured by Breckenridge Pharmaceutical Inc., is $1.3050 per EA (NDC 51991073532), effective Sep 30, 2026.
How has the price of GRANISETRON HCL 1 MG TABLET changed over time?
Over the history we have for it, the NADAC for GRANISETRON HCL 1 MG TABLET has declined 70.8%. It has been tracked across 518 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for GRANISETRON HCL 1 MG TABLET?
Since Nov 28, 2013, the NADAC for GRANISETRON HCL 1 MG TABLET has ranged from a low of $1.0638 (Jun 19, 2024) to a high of $4.4661 (Feb 12, 2014), with a median of $1.8861 per EA.
Are there cheaper alternatives to GRANISETRON HCL 1 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as GRANISETRON HCL 1 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures GRANISETRON HCL 1 MG TABLET?
GRANISETRON HCL 1 MG TABLET (NDC 51991073532) is labeled by Breckenridge Pharmaceutical Inc., and CMS classifies it as a generic product.